Stephen J. Hill, Chief Operating Officer of Lyell Immunopharma, Inc., filed a statement of changes in beneficial ownership on August 25, 2026, reporting a sale of common stock on August 21, 2026, related to the settlement of vested restricted stock units.
Key Highlights
- Reporting person: Stephen J. Hill, identified as Chief Operating Officer of Lyell Immunopharma, Inc.
- Transaction date: 989 shares of common stock were disposed of on August 21, 2026.
- Sale price: Shares were sold at $15.54 per share, according to the filing.
- Purpose of sale: Shares were "automatically sold to cover tax withholding obligation from settlement of vested restricted stock units," per the filing's footnote.
- Remaining ownership: Following the transaction, Hill directly held 16,816 shares of common stock.
- Exchange and ticker: Lyell Immunopharma, Inc. trades under NASDAQ:LYEL.
Transaction Details for Lyell Immunopharma's Chief Operating Officer
According to the filing, Hill disposed of 989 shares of Lyell Immunopharma common stock at $15.54 per share on August 21, 2026. The filing's footnote states that these shares were "automatically sold to cover tax withholding obligation from settlement of vested restricted stock units," indicating the sale was not a discretionary open-market transaction initiated by the officer.
Lyell Immunopharma, Inc. is a clinical-stage cell therapy company focused on developing T cell therapies for cancer, and Hill serves as its Chief Operating Officer. Following the reported disposition, Hill's direct beneficial ownership stood at 16,816 shares of common stock, as disclosed in the filing. No derivative securities transactions were reported in Table II of the filing. The statement was signed by Mark Meltz as attorney-in-fact on August 25, 2026.
What Was Disclosed
The filing reported a single disposition of 989 shares of Lyell Immunopharma common stock by Chief Operating Officer Stephen J. Hill at $15.54 per share, automatically executed to satisfy tax obligations upon RSU vesting, leaving him with 16,816 shares directly held.




Please wait processing your request...